Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Genecure logo — Innovative gene transfer technology aiming to combat genetic...

Genecure

Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998.

Founded 1998 Venture round Total: $2.00M Biotechnology, Health Care

General Information

Company Name Genecure
Founded Year 1998
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Genecure. To contact Genecure, visit genecure.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genecure compare?

A PDF of Genecure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genecure soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genecure

Genecure is a biotechnology company focused on using its patented gene transfer technology to develop treatments for a range of severe human diseases, including genetic disorders, infectious diseases, and various cancers. The company, established in 1998, is headquartered in Norcross, Georgia. Genecure's slogan, "Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998," reflects its dedication to leveraging innovative biotechnological approaches. The company received a $2.00M Venture Round investment on 21 February 2014, showcasing confidence from investors in its technology and development. This investment underlines the potential seen in Genecure's approach to addressing critical medical needs through advanced genetic solutions. With a focus on biotechnology and healthcare, Genecure positions itself at the intersection of cutting-edge science and potentially impactful medical treatments. As it continues to grow and evolve, this company holds promise in its pursuit of combatting challenging diseases at the genetic level.

Business keywords: Gene transfer technology, Genetic disorders, Infectious diseases, Cancer treatments, Biotech startups, Innovative therapies, Norcross, Georgia, Emerging biotech company, Life-threatening diseases, Genetic disease treatments, Infectious disease treatments, Cancer research, Medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.00M -
21 Feb 2014

Genecure Alternatives & Competitors

View All Alternatives
Genecure vs
American Gene Technologies® International Inc.
American Gene Technologies® International Inc. United States

Our mission is to leverage the power of gene and cell therapy to reduce human suffering from serious...

Series F
26 employees
Biotechnology, Health Care
Genecure vs
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals

Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference technology.

Post-IPO Equity
201-500 employees
Biotechnology, Health Care
Genecure vs
Hunterian Medicine
Hunterian Medicine United States

Advancing cures for genetic diseases with innovative CRISPR delivery technology

Grant
6 employees
Biotechnology, Health Care
Compare Genecure vs Hunterian Medicine
View all alternatives

FAQ About Genecure

Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998.
Genecure was founded in 1998.
Genecure operates in Biotechnology and Health Care. Its work centres on Gene transfer technology, Genetic disorders, Infectious diseases and Cancer treatments.
Genecure has completed 1 funding round, raising a total of $2.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Genecure include American Gene Technologies® International Inc., Dicerna Pharmaceuticals, Hunterian Medicine, Adenovir Pharma AB, Orchard Therapeutics - U.S.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genecure and American Gene Technologies® International Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genecure, https://bouncewatch.com/company/genecure, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes